Multiple unit dosage form having a therapeutic agent in combination with a nutritional supplement
View Patent ↗Compositions and methods for combination therapy are provided. The compositions comprise a multiple unit dosage form having both a therapeutic agent and a nutritional supplement. The combination therapy is useful for restoring a nutrient depletion associated with a particular disease state. Additionally, the combination therapy can prevent or attenuate the depletion of a nutrient caused, in whole or in part, by the co-administrated therapeutic drug. Methods of manufacturing the formulations are likewise described.
1. A dosage form for oral administration comprising:
an inner therapeutic agent core comprising a therapeutic agent, wherein the therapeutic agent core is located at the center of the dosage form;
a middle barrier layer disposed directly on and surrounding the inner therapeutic agent core; and
an outer nutritional supplement layer disposed directly on and surrounding the middle barrier layer consisting of a nutritional supplement and one or more additional components selected from the group consisting of a pharmaceutically acceptable carrier, a sweetener, a flavoring agent, a coloring agent, a preservative and an excipient, and wherein the nutritional supplement is selected from the group consisting of biotin, choline, folate, niacin, pantothenic acid, riboflavin, thiamine, vitamin A, vitamin B6, vitamin B12, vitamin C, vitamin E, bromine, cobalt, copper, fluorine, germanium, iodine, iron, magnesium, manganese, molybdenum, potassium, selenium, silicon, zinc, calcium, phosphorous, sodium, sulfur, and vanadium, or combinations thereof.
2. The dosage form of claim 1 , wherein the therapeutic agent is selected from the group consisting of analgesics, anesthetics, anxiolytics, anticonvulsants, antiemetics, bronchodilators, decongestants, anti-proliferatives, antibiotics, anti-virals, chemotherapeutics, immuno-suppressants, hormonal contraceptives, selective estrogen receptor modulators, fertility agents, and anti-pruritics, or combinations thereof.
3. The dosage form of claim 2 , wherein the therapeutic agent is provided in a therapeutically effective amount.
4. The dosage form of claim 1 , wherein the therapeutic agent is selected from anxiolytics, anticonvulsants, antiemetics, hormonal contraceptives, selective estrogen receptor modulators, and fertility agents, or combinations thereof.
5. The dosage form of claim 4 , wherein the therapeutic agent is selected from anxiolytics, hormonal contraceptives, and fertility agents, or combinations thereof.
6. The dosage form of claim 5 , wherein the therapeutic agent is selected from hormonal contraceptives and fertility agents.
7. The dosage form of claim 6 , wherein the therapeutic agent is one or more hormonal contraceptives.
8. The dosage form of claim 6 , wherein the therapeutic agent is one or more fertility agents.
9. The dosage form of claim 1 , wherein the barrier layer is comprised of a controlled-release, delayed-release, sustained release, or enteric coating.
10. The dosage form of claim 1 , wherein the nutritional supplement is provided in a therapeutically effective amount.
11. The dosage form for oral administration of claim 1 , further comprising an outer coating.
12. A method of preventing and/or attenuating depletion of a nutrient caused by the co-administration of a therapeutic agent to an individual in need thereof, comprising:
identifying an individual presenting with nutrient depletion associated with the administration of a therapeutic agent; and
administering to the individual the dosage form of claim 1 , wherein said therapeutic agent causes or exacerbates nutrient depletion, wherein said nutritional supplement prevents and/or attenuates said depletion; and wherein said nutrient is selected from the group consisting of biotin, choline, folate, niacin, pantothenic acid, riboflavin, thiamine, vitamin A, vitamin B6, vitamin B 12, vitamin C, vitamin E, bromine, cobalt, copper, fluorine, germanium, iodine, iron, magnesium, manganese, molybdenum, potassium, selenium, silicon, zinc, calcium, phosphorous, sodium, sulfur, and vanadium, or combinations thereof.
13. The method of claim 12 , wherein said therapeutic agent is selected from anxiolytics, anticonvulsants, antiemetics, hormonal contraceptives, selective estrogen receptor modulators, and fertility agents, or combinations thereof.
14. The method of claim 12 , wherein said therapeutic agent is selected from anxiolytics, hormonal contraceptives, and fertility agents, or combinations thereof.
15. The method of claim 12 , wherein said therapeutic agent is selected from hormonal contraceptives and fertility agents.
16. The method of claim 12 , wherein said therapeutic agent is one or more hormonal contraceptives.
17. The method of claim 12 , wherein said therapeutic agent is one or more fertility agents.
18. The method of claim 12 , wherein said nutritional supplement prevents said nutrient depletion.
19. The method of claim 12 , wherein said nutritional supplement attenuates said nutrient depletion.
20. A dosage form for oral administration comprising:
an inner therapeutic agent core comprising a therapeutic agent, wherein the therapeutic agent comprises an immunosuppressant;
a middle barrier layer disposed over and surrounding the inner therapeutic agent core, wherein the middle barrier layer is comprised of an enteric coating; and
an outer nutritional supplement layer disposed over and surrounding the middle barrier layer consisting of biotin and one or more additional components selected from the group consisting of a pharmaceutically acceptable carrier, a sweetener, a flavoring agent, a coloring agent, a preservative and an excipient.
21. A dosage form for oral administration comprising:
an inner therapeutic agent core comprising a therapeutic agent;
a middle barrier layer disposed over and surrounding the inner therapeutic agent core; and
an outer nutritional supplement layer disposed over and surrounding the middle barrier layer consisting of a nutritional supplement and one or more additional components selected from the group consisting of a pharmaceutically acceptable carrier, a sweetener, a flavoring agent, a coloring agent, a preservative and an excipient, and wherein the nutritional supplement is selected from the group consisting of biotin, choline, folate, pantothenic acid, riboflavin, thiamine, vitamin A, vitamin B6, vitamin B12, vitamin C, vitamin E, bromine, cobalt, copper, fluorine, germanium, iodine, iron, magnesium, manganese, molybdenum, potassium, selenium, silicon, zinc, calcium, phosphorous, sodium, sulfur, and vanadium, or combinations thereof.
22. A dosage form for oral administration comprising:
an inner therapeutic agent core comprising a therapeutic agent, wherein the therapeutic agent core is located at the center of the dosage form;
a middle barrier layer disposed directly on and surrounding the inner therapeutic agent core; and
an outer nutritional supplement layer disposed directly on and surrounding the middle barrier layer consisting of a nutritional supplement, and wherein the nutritional supplement is selected from the group consisting of biotin, choline, folate, niacin, pantothenic acid, riboflavin, thiamine, vitamin A, vitamin B6, vitamin B12, vitamin C, vitamin E, bromine, cobalt, copper, fluorine, germanium, iodine, iron, magnesium, manganese, molybdenum, potassium, selenium, silicon, zinc, calcium, phosphorous, sodium, sulfur, and vanadium, or combinations thereof.